Questions on PPIs, risk, and stress
Posted: Thu Dec 19, 2019 10:43 pm
Dear Helico expert,
In the news this past year there have been many articles revolving around the risks of long-term PPI use. Hypothetically speaking, if someone (like me or anyone else here) were infected with an uncurable H. Pylori strain, is it better for that person to go on long-term PPI use which can increase gastric cancer risk (and other health issues), or not to treat with PPIs and increase gastric cancer risk from untreated gastritis/chronic inflammation? In other words, which is the lesser of the evils/risks?
https://www.cardiovascularbusiness.com/ ... ach-cancer
https://www.health.harvard.edu/diseases ... ach_cancer
https://www.litigationandtrial.com/prot ... ch-cancer/
https://www.ncbi.nlm.nih.gov/pubmed/29852782
"It is likely that hypergastrinemia is the pathogenic factor for gastric carcinogenesis due to PPI. PPI are the only group of drugs that causes long-term hypergastrinemia in the doses used in a clinical setting. Due to the likely carcinogenic effect, PPIs should be used carefully. Moreover, since the carcinogenic effect of Helicobacter pylori (Hp) infection also may be mediated by an increase in gastrin, Hp should be eradicated whenever treatment with PPI is initiated."
Also, I have been recently coming across articles stating that stress can also cause ulcers and gastric cancer independent of H.Pylori infection:
https://www.gastrojournal.org/article/S ... 0174-7/pdf
https://www.cghjournal.org/article/S154 ... 7/fulltext
Would this affect H.Pylori's status as being the primary cause of these diseases?
Thanks in advance!
In the news this past year there have been many articles revolving around the risks of long-term PPI use. Hypothetically speaking, if someone (like me or anyone else here) were infected with an uncurable H. Pylori strain, is it better for that person to go on long-term PPI use which can increase gastric cancer risk (and other health issues), or not to treat with PPIs and increase gastric cancer risk from untreated gastritis/chronic inflammation? In other words, which is the lesser of the evils/risks?
https://www.cardiovascularbusiness.com/ ... ach-cancer
https://www.health.harvard.edu/diseases ... ach_cancer
https://www.litigationandtrial.com/prot ... ch-cancer/
https://www.ncbi.nlm.nih.gov/pubmed/29852782
"It is likely that hypergastrinemia is the pathogenic factor for gastric carcinogenesis due to PPI. PPI are the only group of drugs that causes long-term hypergastrinemia in the doses used in a clinical setting. Due to the likely carcinogenic effect, PPIs should be used carefully. Moreover, since the carcinogenic effect of Helicobacter pylori (Hp) infection also may be mediated by an increase in gastrin, Hp should be eradicated whenever treatment with PPI is initiated."
Also, I have been recently coming across articles stating that stress can also cause ulcers and gastric cancer independent of H.Pylori infection:
https://www.gastrojournal.org/article/S ... 0174-7/pdf
https://www.cghjournal.org/article/S154 ... 7/fulltext
Would this affect H.Pylori's status as being the primary cause of these diseases?
Thanks in advance!